Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Amiodarone (hydrochloride)

Amiodarone hydrochloride, a benzofuran-based Class III antiarrhythmic agent, inhibits WT outwardIhERG tails with an IC50 of ∼45 nM[1]. Amiodarone hydrochloride induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts[2]. Amiodarone hydrochloride can be used in the research of both supraventricular and ventricular arrhythmias[1].

Product Specifications

CAS Number

[19774-82-4]

UNSPSC

12352005

Hazard Statement

H312, H332, H350, H360

Target

Autophagy; Potassium Channel

Type

Reference compound

Related Pathways

Autophagy; Membrane Transporter/Ion Channel

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease; Cancer

Assay Protocol

https://www.medchemexpress.com/Amiodarone-hydrochloride.html

Concentration

10mM

Purity

99.86

Solubility

DMSO : 24.5 mg/mL (ultrasonic; warming)

Smiles

CCCCC1=C(C(C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)=O)C3=C(O1)C=CC=C3.Cl

Molecular Formula

C25H30ClI2NO3

Molecular Weight

681.77

Precautions

H312, H332, H350, H360

References & Citations

[1]Yihong Zhang, et al. Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking. Biochem Pharmacol. 2016 Aug 1;113:24-35.|[2]Sabrina Le Bouter, et al. Long-term amiodarone administration remodels expression of ion channel transcripts in the mouse heart. Circulation. 2004 Nov 9;110 (19) :3028-35.|[3]Jie Weng, et al. Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts. Biomed Pharmacother. 2019 Jul;115:108889.|[4]Punithavathi D, et al. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol. 2003 Aug;139 (7) :1342-50.|[5]Shayeganpour A, et al. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models. Biopharm Drug Dispos. 2005 Sep;26 (6) :249-57.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture and light)

Scientific Category

Reference compound1

Clinical Information

Launched

Citation 01

Cell. 2025 May 29;188 (11) :3013-3029.e19.|Front Bioeng Biotechnol. 2022 Mar 17;10:826093.|Viruses. 2021 Jun 28;13 (7) :1255.|Biochem Biophys Res Commun. 2020 Feb 19;522 (4) :862-868.|Biotechnol Bioeng. 2021 Dec;118 (12) :4687-4698.|Cell. 2022 Dec 8;185 (25) :4801-4810.e13.|Cell. 2023 Nov 22;186 (24) :5363-5374.e16.|Cell. 2025 May 29;188 (11) :3013-3029.e19.|Ecotoxicol Environ Saf. 2021 Apr 1:212:111991.|Ecotoxicol Environ Saf. 2025 Nov 15:307:119433.|Patent. US20180263995A1.|SSRN. 2023 Nov 8.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Dapagliflozin Impurity 249
RM-D160949-01 10 mg

Dapagliflozin Impurity 249

Ask
View Details
Dapagliflozin Impurity 249
RM-D160949-02 25 mg

Dapagliflozin Impurity 249

Ask
View Details
Dapagliflozin Impurity 249
RM-D160949-03 50 mg

Dapagliflozin Impurity 249

Ask
View Details
Dapagliflozin Impurity 249
RM-D160949-04 100 mg

Dapagliflozin Impurity 249

Ask
View Details
NFKBID Antibody, FITC conjugated
A64050-100UG 100 µg

NFKBID Antibody, FITC conjugated

Ask
View Details
Recombinant Peptidyl Prolyl Cis/Trans Isomerase NIMA Interacting Protein 4 (PIN4)
SIPB793Hu01-01 10 µg

Recombinant Peptidyl Prolyl Cis/Trans Isomerase NIMA Interacting Protein 4 (PIN4)

Ask
View Details